Carbohydrate-derived bicyclic selenazolines as new dual inhibitors (cholinesterases/OGA) against Alzheimer's disease

VELUETA-VIVEROS, M., MARTINEZ-BAILEN, M., PUERTA, A., ROMERO-HERNANDEZ, L. L., KŘEN, V., MERINO-MONTIEL, P., MONTIEL-SMITH, S., FERNANDES, M. X., MORENO-VARGAS, A. J., PADRON, J. M., LOPEZ, O., FERNANDEZ-BOLANOS, J. G. Carbohydrate-derived bicyclic selenazolines as new dual inhibitors (cholinesterases/OGA) against Alzheimer's disease. Bioorganic Chemistry. 2022, 127(OCT 2022), 105983. ISSN 0045-2068. E-ISSN 1090-2120. Available: doi: 10.1016/j.bioorg.2022.105983.